Update 2 Program on PMP session
08:00-13:00 Beijing Time
Sep 12, 2021, Sunday
Session Five
|
Topic Psuedomyxoma Peritonei |
||||
|
Moderators: Bhatt. A (India), Guoxiang Cai (蔡国响，China) |
||||
|
Time |
Title |
Speaker |
Country |
Time (min) |
|
08:00-08:02 |
About Prof. David Morris by Bhatt A |
2 |
||
|
08:02-08:18 |
Surgery Research and Drugs Data from an Australian Center |
David Morris |
Australia |
16 |
|
08:18-08:20 |
About Prof. Hongbin Xu by Cai GX |
2 |
||
|
08:20-08:35 |
CRS+HIPEC to Treat PMP at Beijing Aerospace Hospital |
Hongbin Xu（许洪斌） |
China |
15 |
|
08:35-08:37 |
About Prof. Kjersti Flatmark by Bhatt A |
2 |
||
|
08:37-08:47 |
A Peptide Vaccine Targeting Mutated GNAS - A Potential Novel Treatment for Pseudomyxoma Peritonei |
Kjersti Flatmark |
Norway |
10 |
|
08:47-08:49 |
About Prof. Peiming Guo by Cai GX |
2 |
||
|
08:49-09:00 |
Management of Peritoneal Carcinomatosis from Appendiceal Mucinous Adenocarcinoma by Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy: Experience on 48 Patients from a Single Center |
Peiming Guo（郭培明） |
China |
11 |
|
09:00-09:02 |
About Dr. Yang Liu by Cai GX |
2 |
||
|
09:02-09:12 |
Clinical Results of Total Gastrectomy for Patients with Pseudomyxoma Peritonei in a Japanese Center |
Yang Liu（刘洋） |
Japan |
10 |
|
09:12-09:14 |
About Dr. Shigeki Kusamura by Bhatt A |
2 |
||
|
09:14-09:24 |
The Role of Iterative Cytoreductive Surgery (ICRS) +/- HIPEC in the Treatment of Recurrent Pseudomyxoma Peritonei: A PSOCI Registry Study |
Shigeki Kusamura |
Italy |
10 |
|
09:24-09:30 |
Breaking |
6 |
||
|
Moderators: Brendan Moran (UK), Han Liang (梁寒 China) |
||||
|
09:30-09:32 |
About Prof. Santiago-Gonzalez-Moreno by Moran B |
2 |
||
|
09:32-09:48 |
A United Alliance between PSOGI and ESSO: Experiences and Lessons from Continental Europe |
Santiago Gonzalez-Moreno |
Spain |
16 |
|
09:48-09:50 |
About Prof. Zheng Peng by Liang H |
2 |
||
|
09:50-10:15 |
PMP pros and cons |
Zheng Peng（彭正） |
China |
15 |
|
10:15-10:17 |
About Dr. Faheez Mohamed by Moran B |
2 |
||
|
10:17-10:28 |
Update in Pseudomyxoma Peritonei from Surgical Point of View 2020 |
Faheez Mohamed |
UK |
11 |
|
10:28-10:30 |
About Dr. Yulin Lin by Liang H |
2 |
||
|
10:30-10:40 |
GNAS Mutation in PMP Pathology: from Basic Researches to Clinical Applications |
Linyu Lin（林育林） |
China |
10 |
|
10:40-10:42 |
About Dr. Sofia Isabel T. Manlubatan by Moran B |
2 |
||
|
10:42-10:47 |
Disseminated Intravascular Coagulation from Intraperitoneal Oxaliplatin Use for Appendiceal Carcinoma |
Sofia Isabel T. Manlubatan |
The Philippines |
5 |
|
10:47-10:49 |
About Dr. Zhenglong Sun by Liang H |
2 |
||
|
10:49-10:54 |
A Preliminary Study on the Degradation of PMP by AKKermansia Muciniphila |
Zhenglong Sun（孙正龙） |
China |
5 |
|
10:54-11:00 |
Breaking |
6 |
||
|
Moderators: Santiago Gonzalez-Moreno (Spain), Zheng Peng (彭正，China) |
||||
|
11:00-11:02 |
About Prof. Brendan Moran by Santi |
2 |
||
|
11:02-11:18 |
A 30-year Contribution to PSOGI from a British National Center on Peritoneal Surface Malignancy |
Brendan Moran |
UK |
16 |
|
11:08-11:20 |
About Prof. Yan Li by Peng Z |
2 |
||
|
11:20-11:35 |
Consensuses and Controversies in PMP Diagnosis and Treatment in China |
Yan Li（李雁） |
China |
15 |
|
11:35-11:37 |
About Dr. Nima Ahmad by Santi |
2 |
||
|
11:37-11:47 |
Managing Recurrent Pseudomyxoma Peritonei in 430 Patients after Complete Cytoreduction and HIPEC: A Dilemma for Patients and Surgeons |
Nima Ahmad |
UK |
10 |
|
11:47-11:49 |
About MS. Hui Liu by Peng Z |
2 |
||
|
11:49-11:59 |
PMP Patient Advocacy Group: A Nationwide Effort |
Hui Liu（刘晖） |
China |
10 |
|
11:59-12:01 |
About Dr. Dario Baratti by Santi |
2 |
||
|
12:01-12:11 |
Systemic Metastases from Low-Grade and High-Grade Pseudomyxoma Peritonei |
Dario Baratti |
Italy |
10 |
|
12:11-12:13 |
About Dr. Ying Zhang by Peng Z |
2 |
||
|
12:13-12:23 |
The Efficacy and Influencing Factors of Bevacizumab Combined with Cyclophosphamide and Oxaliplatin in the Treatment of Advanced Pseudomyxoma Peritonei: A Single-certer Retrospective Study |
Ying Zhang（张颖） |
China |
10 |
|
12:23-12:25 |
About Prof. Marc Pocard by Santi |
2 |
||
|
12:25-12:35 |
Prevention of Peritoneal Carcinomatosis: Actual Result and Future Solutions for the Surgeon |
Marc Pocard |
France |
10 |
|
12:35-12:37 |
About Dr. Hongshen Tang by Peng Z |
2 |
||
|
12:37-12:47 |
Laparscopic Cytoreduction for PMP |
Hongsheng Tang（唐鸿生） |
China |
10 |
|
12:47-12:48 |
About Niels Kok by Santi |
1 |
||
|
12:48-12:53 |
Basic Scientific Evidence for the Treatment of Peritoneal Metastases |
Niels Kok |
the Netherlands |
5 |
|
12:53-13:00 |
Concluding remarks by Dr. Paul Sugarbaker; Announcing best abstracts by Dr. Yan Li; End of this Session |
7 |
||
